Showing results (71-80 of 82) with videos related to
Sort By:
Pageof 9
Chemotherapy Research and Practice|December 5, 2017
Efficacy of Second-Line Pemetrexed-Carboplatin in EGFR-Activating Mutation-Positive NSCLC: Does Exon 19 Deletion Differ from Exon 21 Mutation?Amit Joshi, Vanita Noronha, Vijay M Patil, et al.South Asian Journal of Cancer|March 24, 2025
Efficacy and Safety of Low-Dose Nivolumab in Treatment of Advanced Solid Tumors: A Retrospective Audit from Resource-Constrained SettingsAmit Kumar, Akhil Kapoor, Vanita Noronha, et al.South Asian Journal of Cancer|December 31, 2025
Real-World Experience of First-Line Osimertinib in EGFR Mutated Non-Small Cell Lung Cancers from a Tertiary Cancer Center, IndiaAtul Tiwari, Ajay Kumar Singh, Vanita Noronha, et al.Indian Journal of Cancer|March 14, 2020
Indian clinical practice consensus guidelines for the management of squamous cell carcinoma of head and neckKumar Prabhash, Govind Babu, Pankaj Chaturvedi, et al.Eclinicalmedicine|June 24, 2022
Mebendazole plus lomustine or temozolomide in patients with recurrent glioblastoma: A randomised open-label phase II trialVijay M Patil, Nandini Menon, Abhishek Chatterjee, et al.British Journal of Cancer|November 26, 2024
Pregabalin for chronic cough due to lung cancer: randomized, double-blind, placebo-controlled trialVanita Noronha, Nandini Menon, Vijay M Patil, et al.Indian Journal of Surgical Oncology|April 25, 2022
An Audit of Systemic Therapy in Medullary Carcinoma ThyroidAditya Pavan Kumar Kanteti, George Abraham, Vijay M Patil, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 21, 2019
Phase I/II Study of Palliative Triple Metronomic Chemotherapy in Platinum-Refractory/Early-Failure Oral CancerVijay M Patil, Vanita Noronha, Amit Joshi, et al.International Journal of Cancer|November 9, 2021
The clinical utility and safety of short-course immune checkpoint inhibitors in multiple tumours-A real-world multicentric study from IndiaGeorge Abraham, Vanita Noronha, Senthil Rajappa, et al.Cancer Medicine|October 31, 2020
COVID-19 in cancer patients on active systemic therapy - Outcomes from LMIC scenario with an emphasis on need for active treatmentAnant Ramaswamy, Lingaraj Nayak, Nirmalya Roy Moulik, et al.Pageof 9